Table 2 Baseline asthma-related medication use in the provincial drug coverage subset (n = 113)
OCS | SABA | ICS | LABA | SAMA | LAMA | Theophylline | ICS + LABA | LTRA | Biologics† | |
|---|---|---|---|---|---|---|---|---|---|---|
Patients with ≥ 1 claim, n (%) | 101 (89.4) | 98 (86.7) | 49 (43.4) | 2–6* | 14–18* | 85 (75.2) | 5–9* | 105 (92.9) | 1–5* | 13 (11.5) |
Total claims, n | 482 | 486 | 187 | NA | 64 | 369 | 43 | 622 | NA | 146 |
Claims per patient, mean (SD) | 4.77 (5.1) | 4.97 (4.5) | 1.65 (2.6) | NA | 0.57 (2.1) | 3.27 (3.2) | 0.38 (1.4) | 5.50 (3.1) | NA | 1.29 (4.0) |
Claims per patient, min–max | 0.0–47.0 | 0.0–20.0 | 0.0–11.0 | NA | 0.0–14.0 | 0.0–14.0 | 0.0–7.0 | 0.0–13.0 | NA | 0.0–21.0 |